Inovio.com

Inovio.com has Server used 198.12.217.25 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2000-02-19 (21 years, 250 days) and hosted in Scottsdale United States, server ping response time 21 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Inovio keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Inovio stock
2 Inovio
3 Inovio pharmaceuticals
4 Inovio stock yahoo forum
5 Inoviopay
6 Inovio pharmaceuticals stocks
7 Inovio 8k
8 Inovio ir
9 Inovio q3

Hosting Provider

Website: Inovio.com
Hostname: ip-198-12-217-25.ip.secureserver.net
Country:
Region: AZ
City: Scottsdale
Postal Code: 85260
Latitude: 33.61190032959
Longitude: -111.89060211182
Area Code: 480
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (12 hours ago)

   » Bobbyjonesband.com (4 hours ago)

   » 1stchoiceautosllc.com (5 hours ago)

   » Huishoubao.com (5 day ago)

   » M1file.com (10 hours ago)

   » Renhomesantalya.com (2 day ago)

   » Napadrivertours.com (4 day ago)

Results For Websites Listing

Found 47 Websites with content related to this domain, It is result after search with search engine

INOVIO Pharmaceuticals

Inovio.com   DA: 14 PA: 14 MOZ Rank: 28

INOVIO URGENTLY FOCUSED ON DEVELOPING COVID-19 DNA VACCINE Because the World Can't Wait LEARN MORE POWERING DNA MEDICINES ™ INOVIO is focused on rapidly bringing to market precisely designed DNA medicines to potentially treat and prevent a range of serious and life-threatening diseases related to HPV, cancer, and infectious diseases

Inovio Pharmaceuticals, Inc. (INO) Stock Price, News

Finance.yahoo.com   DA: 17 PA: 10 MOZ Rank: 28

  • Inovio Pharmaceuticals stock was up 9.3% at $9.22 at last check
  • Inovio Pharmaceuticals Daily Chart Analysis The stock looks to be nearing resistance in what technical traders call an ascending

INOVIO Advances COVID-19 Vaccine Trials San Diego

Sdbj.com   DA: 12 PA: 50 MOZ Rank: 64

  • INOVIO Pharmaceuticals (NASDAQ: INO), a biotechnology company designing DNA medicines, received approval from Mexico’s national health regulatory agency to advance its COVID-19 vaccine candidate to Phase 3 clinical trials
  • This is the latest advancement in the company’s global Phase 2/3 trial, INNOVATE (INOVIO INO-4800 Vaccine Trial for Efficacy), for its DNA vaccine candidate for …

Inovio Is Going After The 'impossible Tumor' Left In The

Fiercebiotech.com   DA: 21 PA: 50 MOZ Rank: 74

Inovio is hoping to change outcomes for patients with glioblastoma using a new DNA medicine combination of INO-5401, INO-9012 and Regeneron-Sanofi’s PD-1 inhibitor Libtayo.

Inovio’s Electrical Device Zaps A COVID-19 Vaccine Into

Spectrum.ieee.org   DA: 17 PA: 50 MOZ Rank: 71

  • Inovio's device uses a technique called electroporation to sneak a DNA vaccine into cells
  • Kate Broderick, Inovio's senior vice president of R&D, has …

So Los Angeles County Is About To Hit Herd Immunity

Msn.com   DA: 11 PA: 50 MOZ Rank: 66

  • Los Angeles County has to give out another 2 million COVID-19 doses to reach 80% immunity among those 16 years old and up, according to The Los Angeles Times

Brenda Garcia

Linkedin.com   DA: 16 PA: 21 MOZ Rank: 43

  • Data Analyst at Inovio Payments, LLC Los Angeles County, CA
  • Sheila Tetangco-Bartolone Executive Director/President at Downey Foundation for Educational Opportunities Cypress, CA

80+ "Pacumio" Profiles LinkedIn

Linkedin.com   DA: 16 PA: 18 MOZ Rank: 41

  • Inovio Pharmaceuticals Inc., +2 more Andrew Pacumio Manager, Online Operations at Wiser San Mateo, CA
  • Wiser Solutions, Inc., +2 more University of California, Davis, +1 more

This Company Boasted To Trump About Its Covid-19 Vaccine

Nytimes.com   DA: 15 PA: 50 MOZ Rank: 73

  • Inovio has not publicly responded to the pending shareholder lawsuits
  • Over the past 10 years, insiders at Inovio have sold more than $25 million …

Inovio COVID-19 Vaccine

En.wikipedia.org   DA: 16 PA: 29 MOZ Rank: 54

  • Inovio is in competition to develop a coronavirus vaccine with numerous other companies, which were conducting preclinical or early-stage human research on more than 170 vaccine candidates, as of late June
  • In April 2020, Inovio began a Phase I trial of the COVID-19 vaccine candidate, INO-4800.

Inovio: Covid-19 Vaccine Opportunity Still At Play Nasdaq

Nasdaq.com   DA: 14 PA: 50 MOZ Rank: 74

  • Inovio: Covid-19 Vaccine Opportunity Still at Play
  • L ast year, as coronavirus stocks became a thing, Inovio Pharmaceuticals ( INO) was one of …

INO Stock: Is Inovio Stock A Buy As It Moves Into Late

Investors.com   DA: 17 PA: 35 MOZ Rank: 63

  • Inovio was founded in 1983 under another name, Genetronics
  • At the time, it focused on a technological platform called electroporation
  • Electroporation is using controlled electrical pulses to

Inovio May Be Losing The Covid-19 Vaccine Race

Msn.com   DA: 11 PA: 50 MOZ Rank: 73

  • Inovio May Be Losing the Covid-19 Vaccine Race
  • Some COVID-19 stocks are on the rebound as the world enters the second wave
  • Many companies are competing to create a …

Inovio Pharmaceuticals

En.wikipedia.org   DA: 16 PA: 28 MOZ Rank: 57

Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases.In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine

Safety, Tolerability And Immunogenicity Of INO-4800 For

Clinicaltrials.gov   DA: 18 PA: 21 MOZ Rank: 53

Inovio Pharmaceuticals: ClinicalTrials.gov Identifier: NCT04336410 Other Study ID Numbers: COVID19-001 : First Posted: April 7, 2020 Key Record Dates: Last Update Posted: October 4, 2021 Last Verified: October 2021 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Yes: Plan Description:

Inovio Pharmaceuticals, Inc. (INO) Latest Stock News

Finance.yahoo.com   DA: 17 PA: 16 MOZ Rank: 48

  • (NASDAQ: INO) shares are trading higher Thursday after the company announced it received regulatory authorization from Brazil’s ANVISA to initiate the global Phase 3

INO Inovio Pharmaceuticals Inc. Stock Overview (U.S

Barrons.com   DA: 15 PA: 23 MOZ Rank: 54

  • engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Inovio Puts Coronavirus Vaccine Trial On Hold To Answer

Usnews.com   DA: 14 PA: 50 MOZ Rank: 81

Inovio, a biotechnology company developing a vaccine for the coronavirus, has put its trial on a partial hold as it answers questions from the Food …

INO: Inovio Pharmaceuticals Inc

Cnbc.com   DA: 12 PA: 11 MOZ Rank: 41

  • (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on …

Inovio Pharmaceuticals, Inc. Common Stock (INO) News

Nasdaq.com   DA: 14 PA: 42 MOZ Rank: 75

  • Inovio Pharmaceuticals, Inc. Common Stock (INO) Nasdaq Listed
  • -0.11 (-1.51%) CLOSED AT 4:00 PM ET ON Sep 30, 2021
  • Data is currently not available

INO Stock Price Inovio Pharmaceuticals Inc. Stock Quote

Marketwatch.com   DA: 19 PA: 20 MOZ Rank: 59

  • engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

INOVIO Completes Enrollment Of Phase 1B Clinical Trial For

Marketwatch.com   DA: 19 PA: 50 MOZ Rank: 90

INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and …

Inovio Pharmaceuticals, Inc. (AMEX:INO), Sinovac Biotech

Benzinga.com   DA: 16 PA: 50 MOZ Rank: 88

The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 …

Inovio Pharmaceuticals, Inc. (INO) Stock Price Today

Seekingalpha.com   DA: 16 PA: 11 MOZ Rank: 50

  • A high-level overview of Inovio Pharmaceuticals, Inc
  • Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Inovio Pharmaceuticals

Crunchbase.com   DA: 18 PA: 36 MOZ Rank: 78

  • INOVIO is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure, and protect people from diseases associated with HPV, cancer, and infectious diseases
  • INOVIO is the first and only company to have clinically demonstrated that DNA medicine can be delivered directly into cells in the body via a

Working At Inovio Pharmaceuticals In San Diego, CA

Indeed.com   DA: 14 PA: 35 MOZ Rank: 74

  • MANAGER, STRATEGIC SOURCING (Former Employee) - San Diego, CA - September 12, 2017
  • While I only worked for Innovio for a short period of time I truly enjoyed the team of people that I worked with
  • The manufacturing team worked very …

What Is Inovio

Foxbusiness.com   DA: 19 PA: 50 MOZ Rank: 95

  • Inovio Pharmaceuticals is a Pennsylvania-based biotech company that's on the cutting edge of the search for a coronavirus vaccine.

Inovio Expects FDA Decision On COVID-19 Vaccine Trial

News.yahoo.com   DA: 14 PA: 48 MOZ Rank: 89

  • Inovio said it provided responses to the FDA's questions in October
  • Shares of Inovio, which closed down 19% at $8.50, were up 4% after hours
  • Inovio's vaccine, known as INO-4800, was designed using the company's novel DNA medicine platform.

Inovio Pharmaceuticals And Advaccine Biopharmaceuticals

Genengnews.com   DA: 18 PA: 50 MOZ Rank: 96

INOVIO said June 8 that it had expanded a previously-announced partnership with Advaccine Biopharmaceuticals Suzhou in order to jointly conduct the global Phase III segment of the ongoing Phase II

Inovio Shares Update On COVID-19 Vaccine, And Its

Inquirer.com   DA: 16 PA: 50 MOZ Rank: 95

  • Inovio’s technology is based on the pioneering work of company cofounder David Weiner, now a vice president of the Wistar Institute, which is collaborating on the Inovio vaccine.
  • The approach involves injecting a synthetic coronavirus gene into the patient
  • The gene instructs cells to make a signature coronavirus protein that triggers an immune response.

Working At Inovio Pharmaceuticals: Employee Reviews

Indeed.com   DA: 14 PA: 35 MOZ Rank: 79

  • Inovio is a pre-commercial bio tech with many pre-clinical and clinical trial programs
  • Work you do has a direct impact on the business
  • There are opportunities to try new things professionally.

Coronavirus Vaccine: This Week's Update From Moderna

Nbcnews.com   DA: 15 PA: 50 MOZ Rank: 96

  • Coronavirus vaccine: This week's update from Moderna, Inovio and more
  • Early progress has been reported on several vaccine efforts, as scientists around the …

Inovio: A Strong Sell (NASDAQ:INO) Seeking Alpha

Seekingalpha.com   DA: 16 PA: 35 MOZ Rank: 83

  • Inovio has run a lot on speculation about its coronavirus vaccine
  • This article shows just how likely successful such an Inovio vaccine is.

INO Stock: Is Inovio Pharmaceuticals The Cure For Your

Investorplace.com   DA: 17 PA: 50 MOZ Rank: 100

  • While INO stock is still mired in red ink, Inovio is the only company with an existing phase 2 vaccine used for the MERS or Middle East Respiratory Syndrome coronavirus

INO Inovio Pharmaceuticals Inc. Company Profile

Wsj.com   DA: 11 PA: 38 MOZ Rank: 83

  • engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Coronavirus Vaccine Tracker: Inovio

India.com   DA: 13 PA: 50 MOZ Rank: 98

Coronavirus Vaccine Tracker: Inovio has asserted that it would respond to FDA's queries in October, after which the regulatory body, within 30 days, have to decide if the final trial should proceed.

Inovio Heads To Brazil For Phase 3 COVID-19 Vaccine Trial

Fiercebiotech.com   DA: 21 PA: 50 MOZ Rank: 14

  • Inovio will take a trip to sunny Brazil to run a phase 3 trial testing a COVID-19 vaccine, months after the U.S
  • turned off the lights for the late-stage study
  • The Plymouth Meeting, Pennsylvania

Inovio Expects FDA Decision On COVID-19 Vaccine Trial

Reuters.com   DA: 15 PA: 50 MOZ Rank: 13

  • Inovio Pharmaceuticals Inc on Monday said it expects the U.S
  • Food and Drug Administration to decide this month whether to allow an advanced trial of the company's experimental COVID-19 vaccine to

INOVIO's Pan-COVID-19 Vaccine Candidate (INO-4802) Induces

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 12

  • INOVIO also is a proud recipient of 2020 Women on Boards "W" designation recognizing companies with more than 20% women on their board of directors
  • For more information, visit www.inovio.com

Inovio Pharmaceuticals, Inc.

Thestreet.com   DA: 17 PA: 10 MOZ Rank: 66

  • engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

Recently Analyzed Sites

Revo.com (12 hours ago)

Bobbyjonesband.com (4 hours ago)

1stchoiceautosllc.com (5 hours ago)

Huishoubao.com (5 day ago)

M1file.com (10 hours ago)

Trekksoft.com (2 day ago)

Tibbo.com (3 hours ago)

Legend3d.com (8 seconds ago)

Tailspinbandsc.com (1 day ago)

Dungscanada.com (2 day ago)

Jfsorange.org (12 hours ago)

Marloweslu.com (5 day ago)